fda removing semaglutide Clears For Cardiac Risk Reduction in Diabetic Patients Drug compounders sue US FDA

Contact Us to learn more about how a specialty compounding pharmacy can work with you and your practitioner to support your journey back to wellness

Some studies show that up to 40% of the weight loss observed in patients on semaglutide is attributable to loss of lean muscle mass, which is viewed as a major shortcoming

How Will it Help Me

Tonums Motus (oral) is a research-backed supplement option that showed 10.4% average weight loss in human clinical trials over six months and can be considered as a complementary, oral approach alongside dietary changes and coaching

The release agent and lubricant talcum which is used for manufacturing of tablets or capsules can contain asbestos fibers